BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 26339719)

  • 1. Oral mucosal involvement and petechial lesions: a SDRIFE case with unusual findings.
    Karadag AS; Ozlu E; Akdeniz N; Uzuncakmak TK; Turkoglu Z; Ozkanli S; Zemheri E
    Cutan Ocul Toxicol; 2016; 35(2):157-9. PubMed ID: 26339719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SDRIFE (baboon syndrome) induced by penicillin.
    Handisurya A; Stingl G; Wöhrl S
    Clin Exp Dermatol; 2009 Apr; 34(3):355-7. PubMed ID: 18699835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symmetrical drug-related intertriginous and flexural exanthema (baboon syndrome) induced by amoxicillin-clavulanate.
    Dogru M; Ozmen S; Ginis T; Duman H; Bostanci I
    Pediatr Dermatol; 2012; 29(6):770-1. PubMed ID: 22044408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by oral metronidazole.
    Şikar Aktürk A; Bayramgürler D; Salman S; Yıldız KD; Odyakmaz Demirsoy E
    Cutan Ocul Toxicol; 2014 Dec; 33(4):337-8. PubMed ID: 24938451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SDRIFE (baboon syndrome) due to paracetamol: case report.
    Lugović-Mihić L; Duvančić T; Vučić M; Situm M; Kolić M; Mihić J
    Acta Dermatovenerol Croat; 2013; 21(2):113-7. PubMed ID: 24001419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir.
    Daito J; Hanada K; Katoh N; Katoh S; Sakamoto K; Asai J; Takenaka H; Kishimoto S
    Dermatology; 2009; 218(1):60-2. PubMed ID: 18974630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome?
    Häusermann P; Harr T; Bircher AJ
    Contact Dermatitis; 2004; 51(5-6):297-310. PubMed ID: 15606657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic drug-related intertriginous and flexural exanthema (SDRIFE).
    Elmariah SB; Cheung W; Wang N; Kamino H; Pomeranz MK
    Dermatol Online J; 2009 Aug; 15(8):3. PubMed ID: 19891911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.
    Winnicki M; Shear NH
    Am J Clin Dermatol; 2011 Jun; 12(3):171-80. PubMed ID: 21469762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case of Intertriginous and Flexural Exanthema caused by Amoxicillin.
    Cancela-Díez B; López-Delgado D; Aneiros-Fernandez J; Ruiz-Villaverde R
    Sultan Qaboos Univ Med J; 2019 Nov; 19(4):e369-e371. PubMed ID: 31897322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symmetrical drug-related intertriginous and flexural exanthema secondary to topical 5-fluorouracil.
    Powers R; Gordon R; Roberts K; Kovach R
    Cutis; 2012 May; 89(5):225-8. PubMed ID: 22768435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symmetrical drug-related intertriginous and flexural exanthema/baboon syndrome induced by traditional Chinese medicine.
    Liu J; Li LF
    J Cosmet Dermatol; 2022 May; 21(5):2200-2204. PubMed ID: 34333850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lenalidomide-induced symmetrical drug-related intertriginous and flexural exanthema.
    Patel RT; Quan EY; Eikenberg JD; Grider DJ; Phillips MA
    Dermatol Online J; 2023 Aug; 29(4):. PubMed ID: 37921816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symmetrical drug related intertriginous and flexural exanthema (SDRIFE) induced by fluconazole: An uncommon side effect of a commonly used drug.
    Kumar S; Bhale G; Brar BK
    Dermatol Ther; 2019 Nov; 32(6):e13130. PubMed ID: 31659833
    [No Abstract]   [Full Text] [Related]  

  • 15. Symmetric drug-related intertriginous and flexural exanthema: Clinicopathologic study of 19 cases and review of literature.
    Schuler AM; Smith EH; Chaudet KM; Bresler SC; Gudjonsson JE; Kroshinsky D; Nazarian RM; Chan MP
    J Cutan Pathol; 2021 Dec; 48(12):1471-1479. PubMed ID: 34159622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients.
    Kirven RM; Fisher K; Kaffenberger BH; Chung CG; Korman AM
    Arch Dermatol Res; 2024 May; 316(6):279. PubMed ID: 38796524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symmetrical drug-related intertriginous and flexural exanthema due to ranitidine.
    Binitha MP; Sasidharanpillai S; John R; Sherjeena PV
    Indian J Pharmacol; 2014; 46(5):551-2. PubMed ID: 25298589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by golimumab.
    Yang SY; Lan CC; Hu SC
    Int J Dermatol; 2017 May; 56(5):571-572. PubMed ID: 28217835
    [No Abstract]   [Full Text] [Related]  

  • 19. Co-occurrence of Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) and Pigmented Fixed Drug Eruption (FDE) in a Single Patient Due to Doxycycline: A Case Report.
    Sahu K; Sirka CS; Pradhan S; Rout AN
    Indian Dermatol Online J; 2020; 11(1):62-64. PubMed ID: 32055511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare case of itraconazole induced SDRIFE (symmetrical drug-related intertriginous and flexural exanthema).
    Koschitzki K; Karrer S; Berneburg M; Niebel D; Drexler K
    J Dtsch Dermatol Ges; 2024 Jun; 22(6):833-836. PubMed ID: 38567643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.